Search Results 1551-1560 of 40501 for Two-phase

1. A Study to Evaluate MesilatE for Treating Hospitalized Patients with COVID-19 (Enrolling by Invitation Only) - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

2. Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

3. Atezolizumab (intravenous route) - Side effects & uses - Mayo Clinic

   It is given to patients who have stage 2 to stage 3A NSCLC and whose tumors express PD-L1. Your doctor will perform a test to check for the PD-L1 tumor ...

4. Deep brain stimulation - Mayo Clinic

   Some people have leads implanted into each side of the brain for a total of two leads. A wire runs under your skin to a device called a pulse generator ...

5. A Study to Evaluate KD025 in Subjects with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

   Overview. Tab Title Description. Study typeInterventional Study phase2. Study ... (two doses) or matched placebo for 28 weeks. The study will be double ...

6. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

   Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

7. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

   Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

8. A Study to Evaluate Ulixertinib to Treat Patients with Advanced Malignancies Harboring MEK or Atypical BRAF Alterations - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

9. Clinical trials - Nuclear Medicine Therapy

   In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with capecitabine ...

10. A Study Evaluating Efruxifermin In Subjects With Compensated Cirrhosis Due To NASH/MASH - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...